Academic Research & Publications  

Book Chapters +

  1. Terence C. Chua, David L. Morris. Synchronous Liver Resection and Cryotherapy for Liver Cancer. In: Cryosurgery for Cancer (KC Xu Editor), 2010.
  2. Terence C. Chua, Jesus Esquivel. Carcinomatosis from colon cancer. In: Regional Cancer Therapy for Advanced Disease (Martin Goodman Editor), 2011.
  3. Terence C. Chua, Winston Liauw, David L. Morris. Colorectal Cancer, Prevention and Treatment of Carcinomatosis. In: Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishing: Woodbury (Paul H Sugarbaker Editor), 2012.
  4. Terence C. Chua, David L. Morris, Tristan D. Yan, Paul H. Sugarbaker. Port-Site Metastasis following Laparoscopic Surgery. In: InTech Advanced Laparoscopy ISBN 978-953-307-674-4 (Ali Shamsa Editor), http://www.intechopen.com/articles/show/title/port-site-metastasis-following-laparoscopic-surgery 2011.
  5. Terence C. Chua, Tristan D. Yan. Diffuse Malignant Peritoneal Mesothelioma – Staging and Treatment. In Chapter on Peritoneal Mesothelioma in Oxford Textbook of Oncology. Oxford University Press.

Abstracts - Local Meetings +

  1. Terence C. Chua, Melissa J. Slavin, Nicky Kochan, Julian N. Trollor, Henry Brodaty, Perminder S. Sachdev. Diffusion Tensor Imaging as a Preclinical Diagnostic Marker for Dementia. Poster Presentation at UNSW Faculty of Medicine, Merck Sharp & Dohme Research Day 10th October 2007 – UNSW, Sydney, Australia.
  2. Terence C. Chua, Wei Wen, Melissa J. Slavin, Nicky Kochan, Julian N. Trollor, Henry Brodaty, Perminder S. Sachdev. Diffusion Tensor Imaging as a Preclinical Diagnostic Marker for Dementia. Oral Presentation at Prince of Wales Hospital Research Day, TOW Research Awards Finalist 9th November 2007 - Edmund Blackett Theatre, Prince of Wales Hospital, Sydney, Australia.
  3. Terence C. Chua, Tristan D. Yan, David L. Morris. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma. Oral Presentation at Royal Australasian College of Surgeons NSW Annual Continuing Education Conference, 16th August 2008 – Sydney, Australia.
  4. Terence C. Chua, Tristan D. Yan, David L. Morris. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma. Poster Presentation at St George Hospital Symposium, 13th November 2008 – Sydney, Australia.
  5. Terence C. Chua, Tristan D. Yan, Zhuli Yap, Matthew D. Horton, Gary G. Fermanis, David L. Morris. Thoracic Cytoreductive Surgery and Intraoperative Hyperthermic Intrathoracic Chemotherapy for Pseudomyxoma Peritonei. Poster Presentation at St George Hospital Symposium, 13th November 2008 – Sydney, Australia.
  6. Terence C. Chua, Peng Yao, Javed Akther, Lawrence Young, Shisan Bao, Ushma Samaraweera, Tristan D. Yan, David L. Morris. Differential expression of Ki-67, estrogen receptor, and progesterone receptor between genders in peritoneal mesothelioma: An immunohistochemistry study that provides a plausible explanation for the better prognosis in females? Oral Presentation at St George Hospital Symposium, 13th November 2008 – Sydney, Australia.
  7. Terence C. Chua, Winston Liauw, Jing Zhao, David L. Morris. Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate. Oral Presentation at Clinical Oncological Society of Australia Annual Scientific Meeting 2011. 9-11th November 2010 – Melbourne, Australia.
  8. Terence C. Chua, Ihssan Al-Alem, Akshat Saxena, Anik Sarkar, Winston Liauw, David L. Morris. Surgical Cytoreduction and Survival in Appendiceal Cancer Peritoneal Carcinomatosis : An Evaluation of 46 Consecutively Treated Patients. Poster Presentation at Clinical Oncological Society of Australia Annual Scientific Meeting 2011. 9-11th November 2010 – Melbourne, Australia.
  9. Terence C. Chua, Philip J. Crowe, David L. Morris. Bibliometric Review of Trends in Surgical Oncology Research in Australia During Period 1998 to 2009. Oral Presentation at Royal Australasian College of Surgeons Annual Scientific Congress, 4th May 2011 – Adelaide, Australia.

Abstracts - International Conference Proceedings +

  1. Terence C. Chua, Wei Wen, Xiaohua Chen, Perminder S. Sachdev. The Substantia Innominata in Mild Cognitive Impairment: Implications as a Potential Biomarker. Poster Presentation at the Human Brain Mapping, 17th June 2008, Melbourne, Australia.
  2. Terence C. Chua, Wei Wen, Xiaohua Chen, Perminder S. Sachdev. The Substantia Innominata in Mild Cognitive Impairment: Implications as a Potential Biomarker. Poster Presentation at the International College of Geriatric Psychopharmaconeurology, 5th September 2008, Sydney, Australia.
  3. Terence C. Chua, Tristan D. Yan, David L. Morris. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma. Poster Presentation at 6th International Workshop on Peritoneal Surface Malignancy, 17-19th November 2008 – Lyon, France.
  4. Terence C. Chua, Tristan D. Yan, Zhu L. Yap, Matthew D. Horton, Gary G. Fermanis, David L. Morris. Cytoreductive Surgery and Intraoperative Hyperthermic Intrathoracic Chemotherapy for Pseudomyxoma Peritonei. Oral Presentation at 6th International Workshop on Peritoneal Surface Malignancy, 17-19th November 2008 – Lyon, France.
  5. Terence C. Chua, Peng Yao, Javed Akther, Lawrence Young, Shisan Bao, Ushma Samaraweera, Tristan D. Yan, David L. Morris. Differential expression of Ki-67, estrogen receptor, and progesterone receptor between genders in peritoneal mesothelioma: An immunohistochemistry study that provides a plausible explanation for the better prognosis in females? Poster Presentation at Annual Cancer Symposium Society of Surgical Oncology, 5th March 2009 – Phoenix, Arizona, USA.
  6. Terence C. Chua, Gregory Robertson, Rhonda Farrell, Tristan D. Yan, David L. Morris. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Carcinomatosis – An Alternative Way of Delivering Intraperitoneal Chemotherapy? Poster Discussion at American Society of Clinical Oncology, Journal of Clinical Oncology, 27:15s, 2009 (suppl; abstr 5524)
  7. Terence C. Chua, Winston Liauw, Akshat Saxena, Francis Chu, Derek Glenn, Alan Chai, David L. Morris. Systematic Review of Randomized and Nonrandomized Trials on the Clinical Efficacy and Safety of Neoadjuvant Transarterial Chemoembolization (TACE) for Resectable Hepatocellular Carcinoma. Oral Presentation at International Liver Cancer Association 3rd Annual Conference, 4th September 2009 – Milan, Italy.
  8. Terence C. Chua, Samantha Martin, Akshat Saxena, Winston Liauw, Tristan D. Yan, Jing Zhao, Irene Lok, David L. Morris. Evaluation of the Cost-Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (Peritonectomy) at the St George Hospital Peritoneal Surface Malignancy Program. Poster Presentation at Annual Cancer Symposium Society of Surgical Oncology, 3rd-7th March 2010 – St Louis, Missouri, USA.
  9. Terence C. Chua, Kelly Thornbury, Akshat Saxena, Winston Liauw, Derek Glenn, Jing Zhao, David L. Morris. Radiofrequency Ablation as an Adjunct to Systemic Chemotherapy for Colorectal Pulmonary Metastases. Poster Presentation at Annual Cancer Symposium Society of Surgical Oncology, 3rd-7th March 2010 – St Louis, Missouri, USA.
  10. Terence C. Chua, Akshat Saxena, Francis Chu, Winston Liauw, Jing Zhao, David L. Morris. Clinicopathological Determinants of Survival after Hepatic Resection of Hepatocellular Carcinoma in 97 Patients – Experience From an Australian Hepatobiliary Unit. Poster Presentation at Annual Cancer Symposium Society of Surgical Oncology, 3rd-7th March 2010 – St Louis, Missouri, USA.
  11. Terence C. Chua, Francis Chu, Patrick S. Butler, Richard J. Quinn, Derek Glenn, Winston Liauw, David L. Morris. Intra-arterial Iodine-131-Lipiodol for Unresectable Hepatocellular Carcinoma. Oral Presentation at Annual Cancer Symposium Society of Surgical Oncology, 3rd-7th March 2010 – St Louis, Missouri, USA.
  12. Akshat Saxena, Terence C. Chua, Lourens Bester, Adel Kokandi, David L. Morris. Factors Predicting Response and Survival after Yttrium-90 Radioembolization of Unresectable Neuroendocrine Tumor Liver Metastases: A Critical Appraisal of 48 Cases. Poster Presentation at Annual Cancer Symposium Society of Surgical Oncology, 3rd-7th March 2010 – St Louis, Missouri, USA.
  13. Akshat Saxena, Lourens Bester, Terence C. Chua, Francis Chu, David L. Morris. Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of this Novel Treatment Option. Poster Presentation at Annual Cancer Symposium Society of Surgical Oncology, 3rd-7th March 2010 – St Louis, Missouri, USA.
  14. Terence C. Chua, Winston Liauw, Jing Zhao, David L. Morris. Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate. Poster Presentation at 7th International Workshop on Peritoneal Surface Malignancy, 8-10th September 2010 – Uppsala, Sweden.
  15. Terence C. Chua, David L. Morris, Akshat Saxena, Jesus Esquivel, Winston Liauw, Joerg Doerfer, Christoph-Thomas Germer, Alexander G. Kerscher, Joerg O. W. Pelz. Influence of Modern Systemic Therapies and its Potential for Cure from Colorectal Peritoneal Carcinomatosis Treated by Cytoreductive Surgery combined with Perioperative Intraperitoneal Chemotherapy: A Multicentre Study. Poster Presentation at 7th International Workshop on Peritoneal Surface Malignancy, 8-10th September 2010 – Uppsala, Sweden.
  16. Terence C. Chua, Abdulaziz Al-Zahrani, Akshat Saxena, Derek Glenn, Winston Liauw, Jing Zhao, David L. Morris. Determining the Association Between Preoperative Computed Tomography Findings and Post-Operative Outcomes after Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei. Poster Presentation at Annual Cancer Symposium Society of Surgical Oncology, 3rd-7th March 2011 – San Antonio, Texas, USA.
  17. Terence C. Chua, Akshat Saxena, Winston Liauw, Francis Chu, David L. Morris. Hepatectomy and Resection of Concomitant Extrahepatic Disease for Colorectal Liver Metastases. Oral Presentation at 5th International Symposium on Abdominal Metastatic Cancer, 4th-5th July 2011 – Regensburg, Germany.
  18. Teremce C. Chua, Brendan J. Moran, Paul H. Sugarbaker, Edward A Levine et al. Early and Long-term Outcome Data on 2298 Patients with Pseudomyxoma Peritonei of Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Poster Presentation at American Society of Clinical Oncology GI Symposium, 19th-21st January – San Francisco, USA.
  19. Terence C. Chua, Akshat Saxena, Winston Liauw, Francis Chu, David L. Morris. Hepatectomy and Resection of Concomitant Extrahepatic Disease for Colorectal Liver Metastases – A Systematic Review. Poster Presentation at 10th World Congress of IHPBA, 1st-5th July – Paris, France.
  20. Terence C. Chua, Francis Chu, Winston Liauw, David L. Morris. Summary Outcomes of Two-Stage Resection of Advanced Colorectal Liver Metastases. Poster Presentation at 10th World Congress of IHPBA, 1st-5th July – Paris, France.
  21. Terence C. Chua, Timothy X. Yang, David L. Morris. Radioembolization and Chemoembolization for Unresectable Neuroendocrine Liver Metastases – A Systematic Review. Poster Presentation at 10th World Congress of IHPBA, 1st-5th July – Paris, France.

Abstracts - Invitational Lecture +

  1. Terence C. Chua. Synchronous Thoracic and Abdomen Pseudomyxoma Peritonei: Thorax or Abdomen First? Lecture Presentation at 7th International Workshop on Peritoneal Surface Malignancy, 8-10th September 2010 – Uppsala, Sweden.
  2. Terence C. Chua. Morbidity of Cytoreductive Surgery and HIPEC – What is Acceptable? Lecture Presentation at 8th International Workshop on Peritoneal Surface Malignancy, 30th Oct-2nd Nov 2012 – Berlin, Germany.

Publications +

  1. Chua TC, Wen W, Slavin MJ, Sachdev PS. (2008). Diffusion tensor imaging in mild cognitive impairment and Alzheimer’s Disease: A Review. Current Opinion in Neurology. 21(1): 83-92.
  2. Chua TC, Yan TD, Morris DL (2009). Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Mesothelioma: The Australian Experience. Journal of Surgical Oncology. 99(2): 109-113.
  3. Chua TC, Yan TD, Morris DL. (2009). Peritoneal Mesothelioma – Current Understanding and Management. Canadian Journal of Surgery. 52(1): 59-64.
  4. Chua TC, Yan TD, Yap ZL, Horton MD, Fermanis GG, Morris DL. (2009). Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei. Journal of Surgical Oncology. 99(5): 292-5.
  5. Chua TC, Yan TD, Saxena A, Morris DL. (2009). Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still Be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality. Annals of Surgery. 249(6): 900-7.
  6. Chua TC, Liauw W, Robertson G, Chia WK, Soo KC, AlObaid A, Al-Mohaimeed K, Morris DL. (2009). Towards Randomized Trials of Peritonectomy and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer Peritoneal Carcinomatosis. Gynecologic Oncology. 114(1): 137-9.
  7. Chua TC, Yan TD, Ng KM, Zhao J, Morris DL. (2009). Significance of lymphatic metastasis in colorectal cancer peritoneal carcinomatosis. World Journal of Surgery. 33(7): 1488-94.
  8. Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, Morris DL. (2009). Long term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: over 10 years experience from a single institution. Annals of Surgical Oncology. 16(7): 1903-11.
  9. Chua TC, Wen W, Chen X, Slavin MJ, Kochan NK, Trollor JN, Brodaty H, Sachdev PS. (2009). Diffusion tensor imaging as a potential marker of mild cognitive impairment. American Journal of Geriatric Psychiatry. 17(7): 602-13.
  10. Chua TC, Liauw W, Morris DL. (2009). The St George Hospital Peritoneal Surface Malignancy Program – Where are we now? ANZ Journal of Surgery. 79(6): 416-8.
  11. Chua TC, Liauw W, Morris DL. (2009). New treatments in peritoneal carcinomatosis. Medical Journal of Australia. 191(1): 3-4.
  12. Chua TC, Koh JL, Yan TD, Liauw W, Morris DL. (2009). Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Small Bowel Adenocarcinoma. Journal of Surgical Oncology. 100(2): 139-43.
  13. Saxena A, Yan TD, Chua TC, Fransi S, Al-Mohaimeed K, Ahmed S, Morris DL. (2009). Predictive Factors for Massive Blood Transfusion in Cytoreductive Surgery: A multivariate analysis of 243 procedures. Annals of Surgical Oncology. 16(8): 2195-203.
  14. Chua TC. (2009). Re: Prevalence and Cost of Full-Time Research Fellowships During General Surgery Residency: A National Survey. Annals of Surgery. 250(2): 352.
  15. Esquivel J, Chua TC. (2009). CT versus Intraoperative Peritoneal Cancer Index in Colorectal Cancer Peritoneal Carcinomatosis: Importance of the Difference of a Statistical Significance and Clinical Relevance. Annals of Surgical Oncology. 16(9): 2662-3.
  16. Chua TC, Liauw W, Robertson G, Morris DL. (2009). Establishing Evidence for Change in Ovarian Cancer Surgery – Proposing Clinical Trials of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer Peritoneal Carcinomatosis. Gynecologic Oncology. 115(1): 166-8.
  17. Chua TC, Al-Mohaimeed K, Liauw W, Morris DL. (2009). Pseudomyxoma Peritonei: A Need to Establish Evidence-Based Standard of Care – Is this the Right Trial? Annals of Surgical Oncology. 16(10): 2675-77.
  18. Chua TC, Pelz JO, Kerscher A, Morris DL, Esquivel J. (2009). Critical Analysis of 33 Patients with Peritoneal Carcinomatosis Secondary to Colorectal and Appendiceal Signet Ring Cell Carcinoma. Annals of Surgical Oncology. 16(10): 2765-70.
  19. Chua TC, Robertson G, Farrell R, Liauw W, Morris DL. (2009). Intraoperative Hyperthermic Intraperitoneal Chemotherapy after Surgical Cytoreduction: Systematic Review of Current Results. Journal of Cancer Research and Clinical Oncology. 135(12): 1637-1645.
  20. Chua TC, Akther J, Yao P, Morris DL. (2009). In-Vivo Model of Pseudomyxoma Peritonei for Novel Candidate Drug Discovery. Anticancer Research. 29(10): 4051-5.
  21. Chua TC. (2009). Gastrointestinal oncological surgery in patients with metastatic cancer treated with angiogenesis inhibitors: safe or not? ANZ Journal of Surgery. 79(10): 672-3.
  22. Saxena A, Chua TC. (2009). Results of Systemic Pemetrexed-Based Combination Chemotherapy versus Cytoreductive Surgery and Hyperthermic Intraperitoneal Cisplatin and Doxorubicin on Survival in Malignant Peritoneal Mesothelioma. Lung Cancer. 66(2): 269-70.
  23. Chua TC, Yan TD, Zhao J, Morris DL. (2009). Peritoneal Carcinomatosis and Liver Metastases from Colorectal Cancer Treated with Cytoreductive Surgery Perioperative Intraperitoneal Chemotherapy and Liver Resection. European Journal of Surgical Oncology. 35(12): 1299-305.
  24. Ding JH, Chua TC, Glenn D, Morris DL. (2009). Feasibility of Ablation as an Alternative to Surgical Metastasectomy in Patients with Unresectable Sarcoma Pulmonary Metastases. Interactive Cardiovascular and Thoracic Surgery. 9(6): 1051-3.
  25. Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH. (2009). Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience. Journal of Clinical Oncology. 27(36): 6237-42.
  26. Chua TC, Yao P, Akther J, Young L, Bao S, Samaraweera U, Yan TD, Morris DL. (2009). Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma. Pathology & Oncology Research. 15(4): 671-8.
  27. Chua TC, Saxena A, Schelleken A, Liauw W, Yan TD, Fransi S, Zhao J, Morris DL. (2010). Mortality and morbidity outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment. Annals of Surgery. 251(1): 101-6.
  28. Chua TC, Martin S, Saxena A, Liauw W, Yan TD, Zhao J, Lok I, Morris DL. (2010). Evaluation of the Cost-Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (Peritonectomy) at the St George Hospital Peritoneal Surface Malignancy Program. Annals of Surgery. 251(2): 323-9.
  29. Saxena A, Bester L, Chua TC, Chu FC, Morris DL. (2010). Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of this Novel Treatment Option. Annals of Surgical Oncology. 17: 484-491.
  30. Chua TC, Saxena A, Liauw W, Kokandi A, Morris DL. (2010). Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver Metastases. Annals of Surgical Oncology. 17: 492-501.
  31. Chua TC, Saxena A. (2010). Pancreatic Cancer Margin Status after Pancreaticoduodenectomy – The Way Forward. Annals of Surgery. 251(4): 755-6.
  32. Saxena A, Chua TC, Bester L, Kokandi A, Morris DL. (2010). Factors Predicting Response and Survival after Yttrium-90 Radioembolization of Unresectable Neuroendocrine Tumor Liver Metastases: A Critical Appraisal of 48 Cases. Annals of Surgery. 261(5): 910-6.
  33. Chua TC, Glenn D, Morris DL. (2010). Extending the Survival of Patients with Melanoma Lung Metastases through Radiofrequency Ablation. Acta Oncologica. 49(4): 517-9.
  34. Yao P, Stanton R, Chua TC, Wines M, Gunasegaram A, Ladd LA, Morris DL. (2010). Hand-assisted Laparoscopic Partial Nephrectomy: A Controlled Study of Bipolar Inline Radiofrequency Ablation Device in Swine. Surgical Innovation. 17(5): 1302-10.
  35. Chua TC, Morris DL, Esquivel J. (2010). Impact of the Peritoneal Surface Disease Severity Score on Survival in Patients with Colorectal Cancer Peritoneal Carcinomatosis Undergoing a Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology. 17(5): 1330-6.
  36. Saxena A, Chua TC, Yan TD, Morris DL. (2010). Postoperative Pancreatic Fistula after Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: Incidence, Risk Factors, Management and Clinical Sequelae. Annals of Surgical Oncology. 17(5): 1302-10.
  37. Saxena A, Yan TD, Chua TC, Morris DL. (2010). A Critical Assessment of Risk Factors for Complications after Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei. Annals of Surgical Oncology. 17(5): 1291-301
  38. Chua TC, Thornbury K, Saxena, A, Liauw W, Glenn D, Zhao J, Morris DL. (2010). Radiofrequency Ablation as an Adjunct to Systemic Chemotherapy for Colorectal Pulmonary Metastases. Cancer. 116(9): 2106-14.
  39. Tudor ECG, Chua TC, Liauw W, Morris DL. (2010). Risk Factors and Clinicopathological Study of Prognostic Factors in the Peritoneal Mesothelioma. American Surgeon. 76(4): 400-5.
  40. Chua TC. (2010). Response to Induction Therapy in Oesophageal and Cardia Carcinoma using Mandard Tumour Regression Grade or Size of Residual Foci. British Journal of Surgery. 97(7): 1146.
  41. Chua TC, Liauw W, Saxena A, Chu F, Glenn D, Chai A, Morris DL. (2010). Systematic Review of Neoadjuvant Transarterial Chemoembolization (TACE) for Resectable Hepatocellular Carcinoma. (2010). Liver International. 30(2): 166-74.
  42. Chua TC, Koong HN. (2010). Curative Pulmonary Metastasectomy for Non Seminomatous Germ Cell Tumor of the Testis. ANZ Journal of Surgery. 80(5): 380-81.
  43. Saxena A, Chua TC, Sarkar A, Chu F, Morris DL. (2010). Clinicopathologic and Treatment-Related Factors Influencing Recurrence and Survival after Hepatic Resection of Intrahepatic Cholangiocarcinoma: A 19-Year Experience from an Established Australian Hepatobiliary Unit. Journal of Gastrointestinal Surgery. 14(7): 1128-38.
  44. Chua TC, Yao P, Akther J, Morris DL. (2010). Impact of Tumor Angiogenesis in Peritoneal Mesothelioma after Radical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. Pathology & Oncology Research. 16(2): 217-22.
  45. Chua TC, Bester L, Akther J, Morris DL. (2010). Successful Right Hepatectomy After Four Treatments of Yttrium-90 Microspheres (SIR-Spheres®) and Concomitant FOLFOX as Bridging Therapy to Resection of Colorectal Liver Metastases. Anticancer Research. 30(7): 3005-7.
  46. Chua TC, Marshall JL, Marshall MB, Esquivel J. (2010). Multi Modality Therapy for Metastatic Colorectal Cancer – Ready for Prime Time? The American Surgeon. 76(7): 777-8.
  47. Morris DL, Chua TC. (2010). Comment on Treatments and Outcomes of Peritoneal Surface Tumors through a Centralized National Service (United Kingdom). Disease of the Colon & Rectum. 52(8): 1219-20.
  48. Chua TC, Saxena A, Chu F, Liauw W, Zhao J, Morris DL. (2010). Clinicopathological Determinants of Survival after Hepatic Resection of Hepatocellular Carcinoma in 97 Patients – Experience From an Australian Hepatobiliary Unit. Journal of Gastrointestinal Surgery. 14(9): 1370-80.
  49. Chua TC, Saxena A. (2010). Extended Pancreaticoduodenectomy with Vascular Resection for Pancreatic Cancer: A Systematic Review. Journal of Gastrointestinal Surgery. 14(9): 1442-52.
  50. Chua TC, Saxena A, Morris DL. (2010). Surgical Metastasectomy in AJCC Stage IV M1c Melanoma Patients with Gastrointestinal and Liver Metastases. Annals Academy Medicine Singapore. 39(8): 634-6.
  51. Chua TC, Sarkar A, Saxena A, Glenn D, Zhao J, Morris DL. (2010). Long-Term Outcome of Image-Guided Percutaneous Radiofrequency Ablation of Lung Metastases: An Open-Labelled Prospective Trial of 148 Patients. Annals of Oncology. 21(10): 2017-2022.
  52. Chua TC, Al-Zahrani A, Saxena A, Liauw W, Zhao J, Morris DL. (2010). Secondary Cytoreduction and Perioperative Intraperitoneal Chemotherapy after Initial Debulking of Recurrent Mucinous Appendix Cancer: A Study of Timing and the Impact of Neoplastic Transformation. Journal of American College of Surgeons. 211(4): 526-535.
  53. Chua TC, Chu F, Butler SP, Quinn RJ, Glenn D, Liauw W, Morris DL (2010). Intra-arterial Iodine-131-Lipiodol for Unresectable Hepatocellular Carcinoma. Cancer. 116(17): 4069-77.
  54. Ding JH, Chua TC, Al-Mohaimeed K, Morris DL. (2010). Hepatocellular Carcinoma Peritoneal Metastases – Report of Three Cases and Collective Review of the Literature. Annals Academy Medicine Singapore. 39(9): 734-4.
  55. Gillern SM, Chua TC, Stojadinovic A, Esquivel J. (2010). KRAS Status in Patients with Colorectal Cancer Peritoneal Carcinomatosis and Its Impact on Outcome. American Journal of Clinical Oncology. 33(5): 456-60.
  56. Chua TC, Liauw W, Robertson G, Morris DL. (2010). Second-Line Treatment of First Relapse Recurrent Ovarian Cancer. Australian New Zealand Journal of Obstetrics and Gynaecology. 50(5): 465-471.
  57. Chua TC, Robertson G, Liauw W, Morris DL. Salvage Cytoreduction for Chemorefractory Ovarian Cancer with Peritoneal Carcinomatosis: A Last Chance or Futile Efforts? (2010). Australian New Zealand Journal of Obstetrics and Gynaecology. 50(5): 478-484.
  58. Esquivel J, Chua TC, Stojadinovic A, Torres Melero J, Levine EA, Gutman M, Howard R, Piso P, Nissan A, Gomez-Portilla A, Gonzalez-Bayon L, Gonzalez-Moreno S, Shen P, Stewart JH, Sugarbaker PH, Barone RM, Hoefer R, Morris DL, Sardi A, Yan TD, Sticca RP. (2010). Accuracy and Clinical Relevance of Computed Tomography Scan Interpretation of Peritoneal Cancer Index in Colorectal Cancer Peritoneal Carcinomatosis: A Multi-Institutional Study. Journal of Surgical Oncology. 102(6): 565-70.
  59. Chua TC. (2010). Progress in the combined modality management of peritoneal carcinomatosis. Journal of Surgical Oncology. 102(7): 728-9.
  60. Chua TC, Yan TD, Baker B, Morris DL. (2010). Palliative Effects of an Incomplete Cytoreduction and Perioperative Intraperitoneal Chemotherapy. American Journal of Clinical Oncology. 33: 568-571.
  61. Chua TC. (2010). Letter to Editor Re: Neoadjuvant Chemotherapy or Debulking Surgery in Stage IIIC and IV Ovarian Cancer. New England Journal of Medicine. 363(24): 2371.
  62. Chua TC, Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Glockzin G, Piso P, Sugarbaker PH. (2011). Multi-Institutional Experience of Diffuse Intra-Abdominal Multicystic Peritoneal Mesothelioma. British Journal of Surgery. 98(1):60-4.
  63. Vanlioglu B, Chua TC. (2011). Presentation of Mumps as Acute Pancreatitis without Parotiditis. Pancreas. 40(1):167-8.
  64. Pelz JO, Chua TC, Esquivel J, Stojadinovic A, Doerfer J, Morris DL, Maeder U, Germer CT, Kerscher AG. (2010). Evaluation of Best Supportive Care and Systemic Chemotherapy as Treatment Stratified According to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for Peritoneal Carcinomatosis of Colorectal Origin. BMC Cancer. 10(1): 689.
  65. Saxena A, Chua TC, Sarkar A, Chu F, Liauw W, Zhao J, Morris DL. (2011). Progression and Survival Results after Radical Hepatic Metastasectomy of Indolent Advanced Neuroendocrine Tumor (NENs) Supports an Aggressive Surgical Approach. Surgery. 149: 209-20.
  66. Chua TC, Liauw W, Yan TD, Saunders V, Fransi S, Zhao J, Saxena A, Morris DL. (2011). Evolution of Loco-Regional Treatment for Peritoneal Carcinomatosis: Experience of 308 Procedures of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy. American Journal of Surgery. 201(2): 149-56.
  67. Chua TC, Morris DL. (2011). Reply to Takao et al. Cancer. 117(4):876-7.
  68. Stojadinovic A, Nissan A, Eberhardt J, Chua TC, Pelz JO, Esquivel J. Development of a Bayesian Belief Network Model for Personalized Prognostic Risk Assessment in Colon Carcinomatosis. American Surgeon. 77(2): 221-30.
  69. Esquivel J, Averbach A, Chua TC. (2011). Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Limited Peritoneal Surface Malignancies: Feasibility, Morbidity and Outcomes in an Early Experience. Annals of Surgery. 253(4):764-8.
  70. Chua TC, Liauw W, Zhao J, Morris DL. (2011). Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate. Annals of Surgery. 253(4):769-773.
  71. Chua TC, Al-Alem I, Saxena A, Liauw W, Morris DL. (2011). Surgical Cytoreduction and Survival in Appendiceal Cancer Peritoneal Carcinomatosis: An Evaluation of 46 Consecutive Patients. Annals of Surgical Oncology. 18(6):1540-6.
  72. Chua TC, Morris DL, Saxena A, Esquivel J, Liauw W, Doerfer J, Germer CT, Kerscher AG, Pelz JO. (2011). Influence of Modern Systemic Therapies as Adjunct to Cytoreduction and Perioperative Intraperitoneal Chemotherapy for Patients with Colorectal Peritoneal Carcinomatosis: A Multicentre Study. Annals of Surgical Oncology. 18(6)1560-7.
  73. Chua TC, Al-Zahrani A, Saxena A, Glenn D, Liauw W, Zhao J, Morris DL. (2011). Determining the Association Between Preoperative Computed Tomography Findings and Post-Operative Outcomes after Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei. Annals of Surgical Oncology. 18(6)1582-9.
  74. Chua TC, Saxena A, Chu F, Zhao J, Morris DL. (2011). Predictors of Cure after Hepatic Resection of Colorectal Liver Metastases: An Analysis of Actual 5- and 10-Year Survivors. Journal of Surgical Oncology. 103(8): 796-800.
  75. Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH and Peritoneal Surface Oncology Group. (2011). A Novel Tumor Node Metastasis (TNM) Staging System of Diffuse Malignant Peritoneal Mesothelioma Based on Outcome Analysis of a Multi-institutional Database. Cancer. 117(9): 1855-63.
  76. Morris DL, Chua TC. (2011). In Reply: Is Malignant Dedifferentiation for Mucinous Appendiceal Neoplasms a Valid Phenomenon or Merely Histopathologic Ambiguity? Journal of American College of Surgeons. 212(5): 907.
  77. Chua TC, Bester L, Saxena A, Morris DL. (2011). Radioembolization and Systemic Chemotherapy Improves Response and Survival for Unresectable Colorectal Liver Metastases. Journal of Cancer Research and Clinical Oncology. 137(5): 865-73.
  78. Chua TC, Saxena A, Chu F, Butler SP, Quinn RJ, Glenn D, Morris DL. (2011). Hepatic Resection With or Without Iodine-131-Lipiodol for Hepatocellular Carcinoma – A Comparative Analysis. International Journal of Clinical Oncology. 16(2): 125-32.
  79. Chua TC, Chu F, Morris DL. (2011). Outcomes of Single-Centre Experience of Hepatic Resection and Cryoablation of Sarcoma Liver Metastases. American Journal of Clinical Oncology. 34(3): 317-20.
  80. Chua TC, Crowe PJ, Morris DL. (2011). Trends in Surgical Oncology Research in Australia - A Bibliometric Review. Journal of Surgical Oncology. 104(2):216-9.
  82. Saxena A, Chua TC, Chu FC, Morris DL. (2011). Improved Outcomes Following Aggressive Surgical Resection of Hilar Cholangiocarcinoma: A Critical Analysis of Recurrence and Survival. American Journal of Surgery. 202(3): 310-20.
  83. Chua TC, Liauw W, Koong HN, Esquivel J. (2011). Surgical Therapies in Metastatic Colorectal Cancer with a Potential for Cure. American Journal of Clinical Oncology. 34(3):326-31.
  84. Chua TC, Saxena A. (2011). Preoperative Chemoradiation followed by Surgical Resection for Resectable Pancreatic Cancer: A Review of Current Results. Surgical Oncology. 20(4): e161-168.
  85. Chua TC, Crowe PJ, Morris DL. (2011). Whither Surgical Oncology? ANZ Journal of Surgery. 81(11): 763-4.
  86. Chua TC, Iyer NG, Soo KC. (2011). Prolonged Survival Following Maximal Cytoreductive Effort for Peritoneal Metastases from Recurrent Granulosa Cell Ovarian Cancer. Journal of Gynecology Oncology. 22(3): 214-7.
  87. Chua TC, Saxena A, Liauw W, Chu F, Morris DL. (2011). Hepatic Resection for Metastatic Breast Cancer: A Systematic Review. European Journal of Cancer. 47(15): 2282-90.
  88. Latif E, Chua TC, Morris DL. (2011). Damage Control Surgery for Liver Rupture Following Selective Internal Radiation Therapy for Unresectable Colorectal Liver Metastases. ANZ Journal of Surgery. 81(7-8): 570-2.
  89. Saxena A, Chua TC, Morris DL. (2011). Surgical Management and Emerging Therapies to Prolong Survival in Metastatic Neuroendocrine Cancer. Annals of Surgical Oncology. 18 Suppl (3): 222-3.
  90. Saxena A, Chua TC, Morris DL. (2011). In Reply: Pseudomyxoma Peritonei: Debulk or Maximal Cytoreduction? Annals of Surgical Oncology. 18(1): 284-285.
  91. Chua TC. (2011). Implications of Upper Abdominal Disease in Advanced Ovarian Cancer after Surgical Cytoreudction and Relation with Tumor Biology. Gynecologic Oncology. 123(3): 615.
  92. Chua TC, Zhao J, Glenn D, Liauw W, Morris DL. (2012). Radiofrequency Ablation of Concomitant and Recurrent Pulmonary Metastases after Surgery for Colorectal Liver Metastases. Annals of Surgical Oncology. 19(1): 75-81.
  93. Chua TC, Liauw W, Chu F, Morris DL. (2012). Viewing Metastatic Colorectal Cancer as a Curable Chronic Disease. American Journal of Clinical Oncology. 35(1): 77-80.
  94. Bester L, Meteling B, Pocock N, Pavlakis N, Chua TC, Saxena A, Morris DL. (2012). Radioembolization versus Standard Care of Hepatic Metastases: Comparative Retrospective Cohort Study of Survival Outcomes and Adverse Events in Salvage Patients. Journal of Vascular Interventional Radiology. 23(1): 96-105.
  95. Klaver YL, Chua TC, de Hingh IH, Morris DL. (2012). Outcomes of Elderly Patients Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Carcinomatosis. Journal of Surgical Oncology. 105(2): 113-8.
  96. Saxena A, Chua TC, Chu F, Morris DL. (2012). Hepatic Resection for Transplantable Hepatocellular Carcinoma for Patients Within Milan and UCSF Criteria. American Journal of Clinical Oncology. 35(2): 141-5.
  97. Ng KM, Chua TC, Saxena A, Zhao J, Chu F, Morris DL. (2012). Two Decades of Experience with Hepatic Cryotherapy for Advanced Colorectal Metastases. Annals of Surgical Oncology. 19(4): 1276-83.
  98. Chua TC, Liauw W, Morris DL. (2012). Early Recurrence of Pseudomyxoma Peritonei Following Treatment Failure of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy is Indicative of a Poor Survival Outcome. International Journal of Colorectal Disease. 27(3): 381-9.
  99. Chua TC, Morris DL. (2012). Therapeutic Potential of Surgery for Metastatic Colorectal Cancer. Scandinavian Journal of Gastroenterology. 47(3): 258-68.
  100. Chua TC, Pelz JO, Morris DL. (2012). Surgery for Colorectal Peritoneal Carcinomatosis. Scandinavian Journal of Gastroenterology. 47(3): 277-285.
  101. Chua TC, Merrett ND. (2012). Clinicopathologic Factors Associated with HER2-Positive Gastric Cancer and its Impact on Survival Outcomes - A Systematic Review. International Journal of Cancer. 130(12): 2845-56.
  102. Chua TC, Morris DL. (2012). Exploring the Role of Resection of Extrahepatic Metastases from Hepatocellular Carcinoma. Surgical Oncology. 21(2): 95-101.
  103. Chua TC, Chong CH, Liauw W, Zhao J, Morris DL. (2012). Inflammatory Markers in Blood and Serum Tumor Markers Predicts Survival in Patients with Epithelial Appendiceal Neoplasms Undergoing Surgical Cytoreduction and Intraperitoneal Chemotherapy. Annals of Surgery. 256(2): 342-9.
  104. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Portilla AG, de Hingh IH, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Van Der Speeten K, Morris DL. (2012). Early and Long-term Outcome Data on 2298 Patients with Pseudomyxoma Peritonei of Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Journal of Clinical Oncology. 30(20): 2449-56.
  105. Chua TC, Morris DL. (2012). Resectable Colorectal Liver Metastases: Optimal Sequencing of Chemotherapy. Journal of Gastrointestinal Cancer. 43(3): 496-498.
  106. Chua TC, Morris DL. (2012). Colorectal Liver Metastases in the Presence of Extrahepatic Disease – A New Criteria for Oncologic Resection. Journal of Gastrointestinal Cancer. 43(3): 502-504.
  107. Chua TC, Chong CH, Liauw W, Morris DL. (2012). Approach to Rectal Cancer Surgery. International Journal of Surgical Oncology. 12:247107.
  108. Saxena A, Chua TC, Perera M, Chu F, Morris DL. (2012). Surgical Resection of Hepatic Metastases from Neuroendocrine Neoplasms: A Systematic Review. Surgical Oncology. 21(3): e131-41.
  109. Chua TC, Scolyer RA, Kennedy CW, Yan TD, McCaughan BC, Thompson JF. (2012). Surgical Management of Melanoma Lung Metastasis: Analysis of Survival Outcomes in 292 Consecutive Patients. Annals of Surgical Oncology. 19(6): 1774-81.
  110. Pillai K, Akhter J, Chua TC, Morris DL. (2012). Mucolysis By Ascorbic Acid and Hydrogen Peroxide on Compact Mucin Secreted in Pseudomyxoma Peritonei. Journal of Surgical Research. 174(2): e69-73.
  111. Chua TC, Saxena A, Liauw W, Chu F, Morris DL. (2012). Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases – A systematic review. European Journal of Cancer. 48(12): 1757-65.
  112. Cao C, Yan TD, Deraco M, Elias D, Glehen O, Levine EA, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH; Peritoneal Surface Malignancy Group. (2012). Importance of Gender in Diffuse Malignant Peritoneal Mesothelioma. Annals of Oncology. 23(6): 1494-8.
  113. Mirarabshahii P, Pillai K, Chua TC, Pourgholami MH, Morris DL. (2012). Diffuse Malignant Peritoneal Mesothelioma – An Update on Treatment. Cancer Treatment and Reviews. 38(6): 605-12.
  114. Chua TC, Chong CH, Morris DL. (2012). Peritoneal mesothelioma: current status and future directions. Surgical Oncology Clinics of North America. 21(4): 635-43.
  115. Chan DL, Morris DL, Rao A, Chua TC. (2012). Intraperitoneal chemotherapy in Ovarian Cancer: A Review of Tolerance and Efficacy. Cancer Management Research. 4:413-22.
  116. Yang TX, Chua TC, Morris DL. (2012). Radioembolization and Chemoembolization for Unresectable Neuroendocrine Liver Metastases – A Systematic Review. Surgical Oncology. 21(4): 299-308.
  117. Pillai K, Akhter J, Chua TC, Morris DL. (2012). Potential Mucolytic Agents for Mucinous Ascites from Pseudomyxoma Peritonei. Investigational New Drugs. 30(5): 2080-6.
  118. Saxena A, Chua TC, Chu F, Al-Zahrani A, Morris DL. (2012). Optimizing the Surgical Effort in Patients with Advanced Neuroendocrine Neoplasm Hepatic Metastases: A Critical Analysis of 40 Patients Treated by Hepatic Resection and Cryoablation. American Journal of Clinical Oncology. 35(5): 439-45.
  119. Yang TX, Chua TC. (2013). Single-Incision Laparoscopic Colectomy versus Conventional Multiport Laparoscopic Colectomy: A Meta-analysis of Comparative Studies. International Journal of Colorectal Disease. 28(1): 89-101.
  120. Bester L, Meteling B, Pocok N, Saxena A, Chua TC, Morris DL. (2013). Radioembolization with Yttrium-90 Microspheres: An Effective Treatment Modality For Unresectable Liver Metastases. Journal of Medical Imaging and Radiation Oncology. 57(1): 72-80.
  121. Zhou WX, Abeysinghe JD, Chua TC. (2013). Mimicry of Appendicitis. ANZ Journal of Surgery. 83(3): 193-4.
  122. Saxena A, Chua TC, Fransi S, Liauw W, Morris DL. (2013). Effectiveness of early and aggressive administration of fresh frozen plasma to reduce massive blood transfusion during cytoreductive surgery. Journal of Gastrointestinal Oncology. 4(1): 30-9.
  123. Chua TC, Liauw W, Chu F, Morris DL. (2013). Summary Outcomes of Two-Stage Resection for Advanced Colorectal Liver Metastases. Journal of Surgical Oncology. 107(2): 211-6.
  124. Yang TX, Morris DL, Chua TC. (2013). Pelvic Exenteration for Rectal Cancer: A Systematic Review. 56(4): 519-31.
  125. Koh JL, Liauw W, Chua T, Morrisl DL. (2013). Carbohydrate Antigen 19-9 is an Independent Prognostic Indicator in Pseudomyxoma Peritonei Post Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy. Journal of Gastrointestinal Oncology. 4(2): 173-81.
  126. Pillai K, Pourgholami MH, Chua TC, Morris DL. (2013). Does the expression of BCL2 have prognostic significnace in malignant peritoneal mesothelioma? American Journal of Cancer Research. 3(3): 312-22.
  127. Klaver YL, Chua TC, Verwaal VJ, de hingh IH, Morris DL. (2013). Secondary Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Recurrence of Colorectal and Appendiceal Peritoneal Carcinomatosis Following Prior Primary Cytoreduction. Journal of Surgical Oncology. 107(6): 585-90.
  128. Chua TC, Quinn LE, Zhao J, Morris DL. (2013). Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Peritoneal Metastases. Journal of Surgical Oncology. 108(2): 81-8.
  130. Pillai K, Akhter J, Chua TC, Morris DL. (2013). Anticancer Property of Bromelain with Therapeutic Potential in Malignant Peritoneal Mesothelioma. Cancer Investigation. 31(4): 241-50.
  131. Chua TC, Esuiqvel J, Pelz JO, Morris DL. (2013). Summary of current therapeutic options for peritoneal metastases from colorectal cancer. Journal of Surgical Oncology. 107(6): 566-73.
  132. Chan DL, Morris DL, Chua TC.(2013). Clinical Efficacy and Predictors of Outcomes of Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma – A Systematic Review. Surgical Oncology. 22(2): e23-30.
  133. Kerscher AG, Chua TC, Gasser M, Maeder U, Kunzmann V, Isbert C, Germer CT, Pelz JO. (2013). Impact of Peritoneal Carcinomatosis in the Disease History of Colorectal Cancer Management: A Longitudinal Experience of 2406 Patients over Two Decades. British Journal of Cancer. 108(7): 1432-9.
  134. Chua TC, Liauw W, Zhao J, Morris DL. (2013). Comparative Analysis of Perioperative Intraperitoneal Chemotherapy Regimen in Determining Survival after Cytoreduction for Appendiceal and Colorectal Peritoneal Carcinomatosis. International Journal of Clinical Oncology. 18(3): 439-46.
  135. Pillai K, Pourgholami MH, Chua TC, Morris DL (2013). Oestrogen Receptors are Prognostic Factors in Malignant Peritoneal Mesothelioma. Journal of Cancer Research and Clinical Oncology. 139(6): 987-94.
  136. Bester L, Feitelson S, Milner B, Chua TC, Morris DL (2013). Impact of Prior Hepatectomy on the Safety and Efficacy of Radioembolization With Yttrium-90 Microspheres for Patients with Unresectable Liver Tumors. American Journal of Clinical Oncology. 57(1): 72-80.
  137. Pillai K, Pourgholami MH, Chua TC, Morris DL. (2013). Ki67-BCL2 index in prognosis of Malignant Peritoneal Mesothelioma. American Journal of Cancer Research. 3(4): 411-23.
  138. Yang TX, Billah B, Morris DL, Chua TC. (2013). Palliative Resection of the Primary Tumor in Patients with Stage IV Colorectal Cancer: Systematic Review and Meta-analysis of Early Outcomes after Laparoscopic versus Open Colectomy. Colorectal Disease. 15(8)e407-19.
  139. Pillai K, Pourgholami MH, Chua TC, Morris DL (2013). MUC1 has Prognostic Significance in Malignant Peritoneal Mesothelioma. International Journal of Biological Markers. 28(3): 303-312.
  140. Ung L , Chua TC, Morris DL. (2013). Peritoneal Metastases of Lower Gastrointetinal Tract Origin: A Comparative Study of Patient Outcomes Following Cytoreduction and Intraperitoneal Chemotherapy. J Cancer Research and Clinical Oncology. 139(11):1899-1908.
  141. Ung L, Chua TC, Morris DL (2013). Cure for Peritoneal Metastases? An Evidence-Based Review. ANZ Journal of Surgery. 83(11): 821-6.
  142. Al-Alem I, Pillai K, Akhter J, Chua TC, Morris DL. (2013). Heat Sink Phenomenon of Bipolar and Monopolar Radiofrequency Ablation Observed Using Polypropylene Tubes for Vessel Simulation. Surgical Innovations. 21(3): 269-276.
  143. Pillai K, Ehteda A, Akhter J, Chua TC, Morris DL. (2014). Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells. Anticancer Drugs. 25(2): 150-60.
  144. Chan DL, Alzahrani NA, Morris DL, Chua TC. (2014). Systematic Review of Efficacy and Outcomes of Salvage Liver Transplantation After Primary Hepatic Resection for Hepatocellular Carcinoma. Journal of Gastroenterology and Hepatology. 29(1):31-41.
  145. Saxena A, Chua TC, Chu FC, Ng KM, Herle P, Morris DL. (2014). Impact of Treatment Modality and Number of Lesions on Recurrence and Survival Outcomes After Treatment of Colorectal Cancer Liver Metastases. Journal of Gastrointestinal Oncology. 5(1): 46-56.
  146. Chua TC, Morris DL. (2014). A Commentary on Concurrent MCL1 and JUN Amplification in Pseudomyxoma Peritonei: A Comprehensive Genetic Profiling and Survival Analysis. Journal of Human Genetics. 59(4): 176-7.
  147. Ung L , Chua TC, Morris DL. (2014). The Importance of Gender in Patients with Peritoneal Metastases of Appendiceal Origin Treated by Cytoreduction and Intraperitoneal Chemotherapy: An Analysis of 257 Consecutive Patients from an Australian Centre. Journal of Cancer Research and Clinical Oncology. 140(6): 1037-45.
  148. Ung L, Lam AK, Morris DL, Chua TC. (2014). Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: a review. Clinical and Translational Oncology. 16(5): 425-35.
  149. Pillai K, Akhter J, Chua TC, Morris DL. (2014). A Formulation for Insitu Lysis of Mucin Secreted in Pseudomyxoma Peritonei. International Journal of Cancer. 134(2): 478-86.
  150. Bester L, Meteling B, Boshell D, Chua TC, Morris DL. (2014). Transarterial Chemoemoblization and Radioembolization for the Treatment of Primary Liver Cancer and Secondary Liver Cancer: A Review of the Literature. Journal of Medical Imaging Radiation Oncology. 58(3): 341-52.
  151. Ung L, Chua TC, Engel AF. (2014) A Systematic Review of Local Excision Combined with Chemoradiotherapy for Early Rectal Cancer. Colorectal Disease. 16(7):502-15.
  152. Williams BH, Alzahrani NA, Chan DL, Chua TC, Morris DL. (2014). Repeat cytoreductive surgery (CRS) for recurrent colorectal peritoneal metastases. European Journal of Surgical Oncology. 40(8): 943-9.
  153. Chua TC, Brown KM, Yan TD. (2013). Sinister cause of abdominal wall bruising. ANZ Journal of Surgery. Nov 19.
  154. Akhter J, Pillai K, Chua TC, Alzarin N, Morris DL. (2014). Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin with potential for treatment through peritoneal catheters. American Journal of Cancer Research. 4(5): 495-507.
  155. Kusamura S, Moran BJ, Sugarbaker PH, Levine EA, Elias D, Baratti D, Morris DL, Sardi A, Glehen O, Deraco M; Peritoneal Surface Oncology Group International (PSOGI); Peritoneal Surface Oncology Group International PSOGI. (2014). Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. British Journal of Surgery. 101(13):1758-65.
  156. Lim RS, Yang TX, Chua TC. (2014). Postoperative bladder and sexual function in patients undergoing surgery for rectal cancer: a systematic review and meta-analysis of laparoscopic versus open resection of rectal cancer. Techniques in Coloproctology. 18(11): 993-1002.
  157. Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R. (2014). The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstituion Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Annals of Surgical Oncology. 21(13): 4195-201.
  158. Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spiliotis J, Torres-Melero J, Turaga K, Trout R. (2014). The American Society of Peritoneal Surface Malignacies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. Journal of Surgical Oncology. 110(7): 779-85.
  159. Pillai K, Pourgholami MH, Chua TC, Morris DL. (2015). MUC1 as a Potential Target in Anti-Cancer Therapies. American Journal of Clinical Oncology. 38(1): 108-18.
  160. Pillai K, Al-Alem I, Akhter J, Chua TC, Shehata M, Morris DL. (2015). Effect of Nonparallel Placement of In-Circle Bipolar Radiofrequency Ablation Probes on Volume of Tissue Ablated with Heat Sink. Surgical Innovations. 22(3): 223-34.
  161. Pillai K, Akhter J, Chua TC, Shehata M, Alzahrani N, Al-Alem I, Morris DL. (2015). Heat sink effect on tumor ablation characteristics as observe in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model. Medicine. 94(9): e580.
  162. Chua TC, Gill AJ, Samra JS. (2015). An unusual cause of torrential lower gastrointestinal hemorrhage. Gastroenterology. 148(5):e10-11.
  163. Chua TC, Wang F, Maher R, Ganadha S, Mittal A, Samra JS. (2015). Endovascualr stenting of mesenterico-portal vein stenosis to reduce blood flow through venous collaterals prior to pancreatoduodenectomy. Langenbecks Arch Surg. 400(5):629-31.
  164. Chan DL, Alzahrani NA, Morris DL, Chua TC. (2015). Systematic review and meta-analysis of hepatic arterial infusion chemotherapy as bridging therapy for colorectal liver metastases. Surgical Oncology. 24(3):162-71.
  165. Pillai K, Pourgholami MH, Chua TC, Morris DL. (2015). Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma. American Journal of Clinical Oncology. 28(4):388-94.
  166. Huang Y, Alzahrani NA, Chua TC, Liauw W, Morris DL. (2015). Impact of low peritoneal cancer idnex on the survival outcomes of patient with peritoneal carcinomatosis of colorectal origin. International Journal of Surgery. 23(PtA):181-5.
  167. Chua TC, Yang TX, Gill AJ, Samra JS. (2016). Systematic review and meta-analysis of enucleation versus standardized resection for small pancreatic lesions. Annals of Surgical Oncology. 23(2):592-9.
  168. Chua TC, de Reuver PR, Staerkle RG, Neale ML, Arena J, Mittal A, Shanbhag ST, Gill AJ, Samra JS. (2016). Transverse closure of mesenterico-portal vein after vein resection in pancreatoduodenectomy. European Journal of Surgical Oncology. 42(2):211-8.
  169. Chua TC, Roseverne LO, Goh AC, Maher R, Samra JS. (2016). Hepatobiliary and Pancreatic: Dual system stenting of the biliary and porto-venous systems to palliate locoregional recurrence of hilar cholangiocarcinoma. Journal of Gastroenterology Hepatology. 31(7): 1239.
  170. Rabindran J, Chua TC, Neale M, Samra JS. (2016). Successful treatment of acute vein graft thrombosis precipitated by delayed sepsis and duodenocaval fistulization. American Surgeon. 82(1):E23-4.
  171. Chua TC, Gill P, Gill AJ, Samra JS. (2016). Ileocecal intussuception caused by an appendiceal neoplasm. Journal of Gastrointestinal Surgery. 20(4):867-8.
  172. Chua TC, Petrushnko W, Mittal A, Gill AJ, Samra JS. (2016). Pancreatic Metastasectomy-an analysis of survival outcomes and prognostic factors. Journal of Gastrointestinal Surgery. 20(6): 1188-93.
  173. Huang Y, Chua TC, Huo YR, Liauw W, Morris DL. (2016). Impact of preoperative serum albumin level on outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy. Annals of Surgical Oncology. 23(8):2411-8.
  174. Huang Y, Alzahrani NA, Chua TC, Huo YR, Morris DL. (2016). Clinical outcomes of patients with extensive peritoneal carcinomatosis following cytoreductive surgery and perioperative intraperitoneal chemotherapy. Anticancer Research. 36(3):1033-40.
  175. Tayao M, Andrici J, Farzin M, Clarkson A, Sioson L, Watson N, Chua TC, Sztynda T, Samra JS, Gill AJ. (2016). Loss of BAP1 Expression is very rare in pancreatic ductal adenocarcinoma. PLoS One. 11(3):e0150338.
  176. Huang Y, Alzahrani NA, Chua TC, Liauw W, Morris DL. (2016). Impacts of peritoneal cancer index on the survival outcomes of patients with colorectal peritoneal carcionmatosis. International Journal of Surgery. 42:65-70.
  177. Chua TC, Marroquin-Harris M, Vasica G. (2016). Not just another case of right iliac fossa pain. Gastroenterology. 151(4):599-600.
  178. Alzahrani N, Ferguson JS, Valle SJ, Liauw W, Chua T, Morris DL. (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia. 86(11):937-941.
  179. Mamoori A, Gopalan V, Lu CT, Chua TC, Morris DL, Smith RA, Lam AK. (2017). Expression pattern of miR-451 and its target MIF (macrophage migration inhibitory factor) in colorectal cancer. Journal of Clinical Pathology. 70(4):308-312.
  180. Huang Y, Alzahrani NA, Chua TC, Liauw W, Morris DL. (2017). Repeat cytoreductive surgery with or without perioperative intraperitoneal chemotherapy for peritoneal surface malignancy. American Journal of Surgery. 213(6):1024-1030.
  181. Huang Y, Chua TC, Maddern GJ, Samra JS. (2017). Robotic cholecystectomy versus conventional laparoscopic cholecystectomy: A meta-analysis. Surgery. 161(3): 628-636.
  182. Pillai K, Akhter J, Mekkawy A, Chua TC, Morris DL. (2017). Physical and chemical characeristics of mucin secreed by pseudomyxoma perionei (PMP). International Journal of Medical Sciences. 14(1):18-28.
  183. Watson M, Townend P, Chua TC, Pincott SJ. (2017). Rare differential of right iliac fossa pain. ANZ Journal of Surgery. 87(3): 208-209.
  184. Huang Y, Chua TC, Gill AJ, Samra JS. (2017). Impact of perioperative fluid adminstration on early outcomes after pancreatoduodenecomy: A meta-analysis. Pancreatology. 17(3): 334-341.
  185. Chua TC, Mittal A, Arena J, Sheen A, Gill AJ, Samra JS. (2017). Resection margin influences survival after pancreatoduodenectomy for distal cholangiocarcinoma. American Journal of Surgery. 213(6):1072-1076.
  186. Chua TC, Roseverne LO, Edwards PD, Sandanayake NS, Cho S, Ooi M, Samra JS. (2017). Gastrointestinal: Intractable delayed gastrointestinal bleeding after pancreatoduodenectomy. J Gastroenterol Hepatol. 32(4): 735.
  187. Huang Y, Alzahrani NA, Chua TC, Morris DL. (2017). Histological subtype remains a significant prognostic factor for survival outcomes in patients with appendiceal mucinous neoplasm with peritoneal dissemination. Dis Colon Rectum. 60(4): 360-367.
  188. Stephenson D, Nahm C, Chua T, Gill A, Mittal A, de Reuver P, Samra J. (2017). Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis. Oncotarget. 8(63):107223-107236.
  189. Itchins M, Arena J, Nahm CB, Rabindran J, Kim S, Gibbs E, Bergamin S, Chua TC, Gill AJ, Maher R, Diakos C, Wong M, Mittal A, Hruby G, Kneebone A, Pavlakis N, Samra JS, Clarke S. (2017). Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resecable pancreatic ductal adenocarcinoma in a high volume referral centre. Eur J Surg Oncol. 43(9):1711-1717.
  190. Gill P, Chua TC, Huang Y, Mehta S, Mittal A, Gill AJ, Samra JS. (2018). Pancreatoduodenectomy and the risk of complications from perioeprative fluid adminsiration. ANZ Journal of Surgery. 88(4): E318-323.
  191. Townend P, de Reuver PR, Chua TC, Mittal A, Clark SJ, Pavlakis N, Gill AJ, Samra JS. (2018). Histopathological tumor viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: analysis of early outcome data. ANZ Journal of Surgery. 88(3):E167-172.
  192. Chua TC, Mittal A, Nahm C, Hugh TJ, Arena J, Gill AJ, Samra JS. (2018). Pancreatoduodenectomy in a public versus private teaching hospital in comparable with some minor variations. ANZ Journal of Surgery. 88(6): E526-531.
  193. Huang Y, Chua TC, Saw RPM, Young CJ. (2018). Discrimination, Bullying and Harassment in Surgery: A Systematic Review and Meta-analysis. World J Surg. 42(12): 3867-73.
  194. Huang Y, Alzahrani NA, Fisher OM, Chua TC, Kozman MA, Liauw W, Arrowaili A, Valle SJ, Morris DL. (2019). Intraoperative macroscopic tumor consistency is associated with overall survival after cytoreductive surgery and intraoperative chemotherapy for appendiceal adenocarcinoma with peritoneal metastases: A retrospective observational study. Am J Surg. 217(4): 704-712.
  195. Singh G, Nahm CB, Jamieson NB, Chua TC, Wong S, Thoo C, Mittal A, Gill AJ, Samra JS. (2019). Management of post-pancreatectomy haemorrhage using resuscitative endovascular balloon occlusion of the aorta. Langenbecks Arch Surg. 404(2): 253-255.
  196. Gill P, Kim E, Chua TC, Clifton-Bligh RJ, Nahm CB, Mittal A, Gill AJ, Samra JS. (2019). MiRNA-3653 is a potential tissue biomarker for increased metastatic risk in pancreatic neuroendocrine tumors. Endocr Pathol. 30(2): 128-133.
  197. Reardon R, Chua TC, Cross J, Curtin A. (2019). Rare differential for large bowel obstruction. ANZ Journal of Surgery. 89(7-8): 962-963.
  198. Chua TC, Jeyakumar A, Ip JC, Yuide PJ, Burstow MB. (2020). Conservative management of acute perforated diverticulitis: A systematic review. J Dig Dis. 21(2): 63-68.
  199. Bong CY, Yuide PJ, Burstow MJ, Chua TC. (2019). Sigmoid volvulus – Mischief from a gravid uterus. ANZ Journal of Surgery. (Epub).
  200. Mackay TG, Rivera DR, Iyengar K, Chua TC. (2019). Mimicry of nodules as an unusual cause of small bowel obstruction. ANZ Journal of Surgery. (Epub).
  201. Anderson T, Yuide PJ, Chua TC. (2019). Beyond the Endoscope. Gastroenterology. (Accepted).
  202. Donovan A, Tabone R, Yuide PJ, Chua TC. (2019). Small bowel obstruction from an appendiceal tie. ANZ Journal of Surgery. (Accepted)
  203. Itchins M, Chua TC, Arena J, Jamieson NB, Nahm CB, O’Connell RL, Bailey EA, Schembri GP, Gill AJ, Kneebone A, Hruby G, Mittal A, Pavlakis N, Clarke SJ, Samra JS. (2020). Evaluatoin of Flurodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal Adenocarcinoma. Pancreas. 49(2): 224-229. (Epub).
  204. Dissanayake B, Burstow MJ, Jeyakumar A, Yuide PJ, Gundara J, Chua TC. (2020). Operative surgery is rarely required in the acute management of diverticulitis in the modern era. Am Surg. (Accepted).